Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
10,819,580
-
Share change
-
-1,700,645
-
Total reported value
-
$28,778,000
-
Price per share
-
$2.66
-
Number of holders
-
18
-
Value change
-
-$3,121,071
-
Number of buys
-
8
-
Number of sells
-
11
Institutional Holders of BIOLINERX LTD - SPONSORED ADR (BLRX) as of Q2 2015
As of 30 Jun 2015,
BIOLINERX LTD - SPONSORED ADR (BLRX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,819,580 shares.
The largest 10 holders included
Senvest Management, LLC, Broadfin Capital, LLC, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., DEUTSCHE BANK AG\, MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, Nine Chapters Capital Management LLC, Benchmark Capital Advisors, and Menta Capital LLC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.